Sign up Australia
Proactive Investors - Run By Investors For Investors

Uscom to lift cash balance to advance medical device commercialisation strategy

The halt will remain in place until Tuesday 19th December 2017.
Uscom to lift cash balance to advance medical device commercialisation strategy
The company's shares are in pre-open

Uscom Ltd (ASX:UCM) remains focused on cardiovascular and pulmonary medical devices, and is developing new non-invasive technologies to address the challenges of global disease and health care.

The company recently delivered record revenue, sales and cash receipts, and has seven new products for China, Europe and the U.S.

To advance the next steps, Uscom is heading to market with a capital raising, and the ASX has granted a trading halt to prepare.

The halt will remain in place until the opening of trade on Tuesday 19th December 2017, or earlier if an announcement is made to the market.

View full UCM profile View Profile

Uscom Ltd Timeline

Related Articles

myLotus kit
August 06 2018
The expansion drive is targeting an estimated 2.3mln women per year in the areas of Hebei, Shanghai, Beijing, Shangdong, Henan and Liaoning
Widecells
September 28 2018
WideCells has undertaken a review of the business to deliver a strategy that will generate revenue, reduce overheads and achieve profitability
cells
July 31 2018
Life science generally is developing at an incredible speed, says Joe Anderson

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use